3. Remdesivir
This drug was developed to treat Ebola and now is also an experimental antiviral drug, says the World Health Organization (WHO). Although it failed against that vicious infection, it has shown effectiveness against MERS and SARS in laboratory and animal tests.
As you probably know, both MERS (Middle East Respiratory Syndrome) and SERS (Severe Acute Respiratory Syndrome) are related to the current Covid-19 virus, leading medical experts to assume that remdesivir might also work against COVID-19.
Remdesivir actually works by interfering with the virus’s ability to replicate, explains Dr. Desruisseaux, who is also an associate professor of internal medicine in the section of infectious diseases at Yale University School of Medicine in New Haven, Connecticut. The drug interfered with the virus’s capacity to replicate in cell cultures.
“We should have the results soon on whether or not it is effective in patients with Covid-19,” says Dr. Desruisseaux.
Now, this drug is in Phase 3 clinical trials and the results are expected in April or May. And, even if the results from those clinical trials are positive, however, remdesivir still needs to go through an approval process. Right now, patients can have access to remdesivir through a clinical trial or on a “compassionate use” basis, says the CDC.
1 thought on “The Most Promising Medical Treatments for COVID-19”
It is not true that the long-proven Cathcart Titration Method is either dangerous (it has never harmed anyone) nor that it has ever failed with any Corona virus. Various desperate trials have shown promise despite the failure of medical efforts to utilize the actual treatment. Trials by physicians with “megadoses” have not used the correct amounts (200-300 grams per day) but instead tiny fractions of the needed amounts (never reported, but almost certainly), and have still saved lives according to the NYT. It is an ongoing crime by physicians and researchers that has cost millions of lives over tge 42 years since Cathcart’s research was first published (ChemTech, Feb 1978).